promise

Kidney Healthcare

Novartis Says Conditionally Approved Kidney Drug Shows Long-Term Promise – Novartis (NYSE:NVS)

6 months ago admin

On Friday, Novartis AG (NYSE:NVS) shared final results from the Phase 3 ALIGN study supporting a slowing decline in kidney...

Kidney Healthcare

Glucarpidase shows promise in treating kidney toxicity from methotrexate

2 years ago admin

An FDA-approved medication called glucarpidase could serve as an antidote to kidney toxicity in patients receiving the chemotherapy drug methotrexate...

Novartis Says Conditionally Approved Kidney Drug Shows Long-Term Promise – Novartis (NYSE:NVS)

Glucarpidase shows promise in treating kidney toxicity from methotrexate

Differences in healthcare resource utilization by race/ethnicity among moderate to late preterm infants with respiratory distress Syndrome, Northern California

VARON Recommends Winter Respiratory Care as Germany Faces Seasonal Health Challenges

Male kidney donors may face higher chance of developing scrotal condition, study finds – Schulich School of Medicine & Dentistry

Clinical Excellence in Respiratory Care returns in May

Novartis Says Conditionally Approved Kidney Drug Shows Long-Term Promise – Novartis (NYSE:NVS)

Glucarpidase shows promise in treating kidney toxicity from methotrexate

You may have missed

Differences in healthcare resource utilization by race/ethnicity among moderate to late preterm infants with respiratory distress Syndrome, Northern California

VARON Recommends Winter Respiratory Care as Germany Faces Seasonal Health Challenges

Male kidney donors may face higher chance of developing scrotal condition, study finds – Schulich School of Medicine & Dentistry

Clinical Excellence in Respiratory Care returns in May